FDA approves Novavax COVID-19 shot but with unusual restrictions
The FDA granted approval for use in adults 65 and older – or those 12 to 64 who have at least one health problem that puts them at increased risk from COVID-19…
The FDA granted approval for use in adults 65 and older – or those 12 to 64 who have at least one health problem that puts them at increased risk from COVID-19…
Read More
About Author
